⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

Official Title: A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

Study ID: NCT01486368

Interventions

PF-03446962

Study Description

Brief Summary: This is a non-randomized open label multicentre Phase II trial to evaluate the response rate of PF03446962 in patients with advanced malignant pleural mesothelioma who have been previously treated with cytotoxic chemotherapy.

Detailed Description: To assess the efficacy (response rate, complete and partial) of PF-03446962 given by IV infusion Day 1 of a 2 week cycle (14 days = 1 cycle) in patients with advanced malignant pleural mesothelioma and previously treated with cytotoxic therapy. To assess the toxicity, safety and tolerability of PF-03446962. To assess the duration of response or stable disease, stable disease rate, progression-free, median and overall survival rates. To collect tissue and blood for banking and correlative science evaluation.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Cross Cancer Institute, Edmonton, Alberta, Canada

BCCA - Fraser Valley Cancer Centre, Surrey, British Columbia, Canada

BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada

CancerCare Manitoba, Winnipeg, Manitoba, Canada

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada

Ottawa Health Research Institute - General Division, Ottawa, Ontario, Canada

Univ. Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada

Contact Details

Name: Quincy Chu

Affiliation: Cross Cancer Institute, Edmonton, AB Canada

Role: STUDY_CHAIR

Name: Paul Wheatley-Price

Affiliation: Ottawa Health Research Institute - General Division, Ottawa ON Canada

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: